# Laser-assisted Topical Administration of Etanercept (Enbrel®) in Patients With Mild to Moderate Plaque-type Psoriasis

> **NCT02999776** · PHASE1 · UNKNOWN · sponsor: **Pantec Biosolutions AG** · enrollment: 30 (estimated)

## Conditions studied

- Psoriatic Plaque

## Interventions

- **DEVICE:** Laser microporation alone
- **DRUG:** Standard of care-daily administration of Daivobet
- **DRUG:** Laser microporation + topical application of Etanercept

## Key facts

- **NCT ID:** NCT02999776
- **Lead sponsor:** Pantec Biosolutions AG
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-11
- **Primary completion:** 2017-12
- **Final completion:** 2018-06
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2016-12-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02999776

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02999776, "Laser-assisted Topical Administration of Etanercept (Enbrel®) in Patients With Mild to Moderate Plaque-type Psoriasis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02999776. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*